First Onset of IgA Vasculitis and Nephritis Following COVID-19 Vaccination.
| Autor: | Martínez-Ortega JI; Department of Dermatology, Dermatological Institute of Jalisco 'Dr. José Barba Rubio', Zapopan, MEX., Perez-Hernandez F; Department of Internal Medicine, Hospital Regional de Alta Especialidad de la Peninsula de Yucatan, Merida, MEX., Fernández-Reyna I; Department of Dermatology, Centro Dermatologico de Yucatan, Mérida, MEX., Eljure Lopez N; Department of Dermatology, Centro Dermatologico de Yucatan, Mérida, MEX. |
|---|---|
| Jazyk: | angličtina |
| Zdroj: | Cureus [Cureus] 2023 Jul 25; Vol. 15 (7), pp. e42448. Date of Electronic Publication: 2023 Jul 25 (Print Publication: 2023). |
| DOI: | 10.7759/cureus.42448 |
| Abstrakt: | The article presents a case of a 32-year-old male who developed IgA vasculitis (IgAV) and IgA vasculitis nephritis (IgAVN) after receiving the second dose of the AstraZeneca COVID-19 vaccine. IgAVN can be a rare side effect of COVID-19 vaccines. Healthcare providers should be aware of this potential adverse event, and promptly recognize and manage it. However, the benefits of vaccination in reducing the morbidity and mortality associated with COVID-19 far outweigh the risks of this rare adverse event. Competing Interests: The authors have declared that no competing interests exist. (Copyright © 2023, Martínez-Ortega et al.) |
| Databáze: | MEDLINE |
| Externí odkaz: |
|